Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

151.97
-3.4900-2.24%
Post-market: 151.970.00000.00%19:51 EDT
Volume:791.03K
Turnover:121.61M
Market Cap:7.48B
PE:-52.18
High:158.51
Open:157.67
Low:151.68
Close:155.46
52wk High:228.88
52wk Low:91.86
Shares:49.22M
Float Shares:48.62M
Volume Ratio:0.82
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9122
EPS(LYR):-2.9122
ROE:-4.23%
ROA:4.24%
PB:2.36
PE(LYR):-52.18

Loading ...

Atara's Outlook As Ebvallo Hits Second FDA CRL

Benzinga_recent_news
·
Jan 15

Charles River Labs Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jan 13

Charles River Laboratories Highlights Market Leadership and Expansion Plans in Latest Healthcare Conference Presentation

Reuters
·
Jan 13

Charles River price target raised to $260 from $250 at Evercore ISI

TIPRANKS
·
Jan 13

Baird Adjusts PT on Charles River Laboratories International to $231 From $224, Keeps Outperform Rating

MT Newswires Live
·
Jan 13

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Option Care Health (OPCH)

TIPRANKS
·
Jan 13

Charles River Laboratories International Inc : Baird Raises Target Price to $231 From $224

THOMSON REUTERS
·
Jan 13

Charles River to buy Cambodia-based monkey supplier for $510 million

Reuters
·
Jan 13

Charles River to buy KF Cambodia for $510M, exercises option for Pathoquest

TIPRANKS
·
Jan 13

BRIEF-Charles River Laboratories Provides Business Updates

Reuters
·
Jan 13

Charles River Laboratories to Acquire K.F. (Cambodia) and PathoQuest SAS

Reuters
·
Jan 13

Charles River Laboratories International - Pathoquest Deal Not Expected to Have Material Impact on Charles River's 2026 or 2027 Financial Results

THOMSON REUTERS
·
Jan 13

Charles River Laboratories International Inc - Proposed Acquisition Valued at $510 Mln

THOMSON REUTERS
·
Jan 13

Charles River Laboratories International Inc - K.f. Is Not Expected to Generate Meaningful Third-Party Revenue Going Forward

THOMSON REUTERS
·
Jan 13

Charles River Laboratories International: Sees Top End of Guidance Range for 2026 Organic Revenue Growth Will Be at Least Flat

THOMSON REUTERS
·
Jan 13

Charles River Laboratories International Inc: Signs Agreement to Acquire K.f. (Cambodia) Ltd. to Further Strengthen Dsa Supply Chain

THOMSON REUTERS
·
Jan 13

Charles River Laboratories International - Deal to Be Accretive to Adj Earnings per Share by About $0.25 in 2026 and Approximately $0.60 in 2027

THOMSON REUTERS
·
Jan 13

Why Charles River (CRL) Is Up 9.1% After Naming Long‑Time Insider Birgit Girshick CEO

Simply Wall St.
·
Jan 11

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 10

Charles River Laboratories Boosts CEO Pay with $1.2 Million Salary and $9 Million Equity Grant

Reuters
·
Jan 10